Clinical Trial

Targeting IRAK4 in Chronic Lymphocytic Leukemia

Name: Targeting IRAK4 in Chronic Lymphocytic Leukemia — clinical trial record (NCT07741695)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PS-CLL016

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests. Leukemic B cells and peripheral blood mononuclear cells (PBMC).

Trial Details

NCT Number	NCT07741695
Lead Sponsor	IRCCS San Raffaele
Conditions	Chronic Lymphocytic Leukemia (CLL)
Enrollment	50 participants
Start Date	2026-09
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-08-04